2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow PAS-004 Tablets: new trials by email Literature Review of PAS-004 Tablets trials Research Report on PAS-004 Tablets
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas PAS-004 Tablets - NF1 Mutation, Neurofibroma Plexiform | Phase 1 | Recruiting | Pasithea Therapeutics Corp. | 56 | 2025-05-30 | 2025-12-04 |
| PAS-004 in Patients With Advanced Solid Tumors PAS-004 Capsules, PAS-004 Tablets - RAS Mutation, NF1 Mutation | Phase 1 | Recruiting | Pasithea Therapeutics Corp. | 48 | 2024-02-29 | 2025-12-03 |
Neoplasms (1) · Neurofibroma, Plexiform (1) · Neurofibromatoses (1) · Neurofibromatosis 1 (1)
Pasithea Therapeutics Corp. (2)
United States (2) · Australia (1) · Bulgaria (1) · Romania (1) · South Korea (1)